HeartBeam, Inc.

HeartBeam, Inc.

BEAT·NASDAQ

$1.47

+8.1%
HealthcareMedical - Healthcare Information Services

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

At a Glance

Live Snapshot
Market Cap$50.63M
EPS-0.6200
P/E Ratio-3.85
Earnings Date05/07/2026

beat

Total Stockholders' Equity

Last Annual Value

2.60M

3-Year CAGR

3%

5-Year CAGR

21%

10-Year CAGR

-29%

HeartBeam, Inc.

HeartBeam, Inc. Competitors Analysis of Total Stockholders' Equity

BEAT · NASDAQ
CompanyTotal Stockholders' Equity
CAGR 3Y
CAGR 5Y
CAGR 10Y
BEAT logo
HeartBeam, Inc.
NASDAQ:BEAT
2.60M
-45.3%-28.0%-32.8% 
28.60M
8.2%-15.5%N/A
42.52M
-17.8%-17.5%N/A
26.43M
-10.7%-16.6%5.7%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
6.31M
-30.6%-20.7%N/A
54.12M
-23.0%-22.5%N/A
MNOV logo
MediciNova, Inc.
NASDAQ:MNOV
41.59M
-12.6%-13.1%1.9%
-15.94M
N/AN/AN/A
-14.23M
N/AN/AN/A
24.80M
-39.4%-30.5%N/A
811.49K
N/AN/AN/A
HeartBeam, Inc.

HeartBeam, Inc. Fair Value Envelope

BEAT · NASDAQ

Our analysis suggests that BEAT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.47, this represents a potential HIDDEN relative to our calculated worth for HeartBeam, Inc..

Intrinsic Value
Current Price: $1.47